Prevalence of Metabolic-Associated Steatohepatitis (MASH) and Advanced Fibrosis in At-Risk Pediatric Populations

被引：0
|
作者：
Kim, Yestle [1 ]
Charlton, Michael [2 ]
Rezvani, Geoff [1 ]
Saal, Gauri B. [3 ]
机构：
[1] Madrigal Pharmaceut, Conshohocken, PA USA
[2] Univ Chicago Med, Chicago, IL USA
[3] Neulum Consulting, Solihull, England
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036672.48353.6c
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1826
引用
收藏
页码：S1316 / S1317
页数：2
相关论文
共 50 条
  • [1] Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
    Noureddin, Mazen
    Truong, Emily
    Mayo, Rebeca
    Martinez-Arranz, Ibon
    Banales, Jesus M.
    Minchole, Itziar
    Arrese, Marco
    Cusi, Kenneth
    Arias-Loste, Maria Teresa
    Bruha, Radan
    Romero-Gomez, Manuel
    Iruzubieta, Paula
    Aller, Rocio
    Ampuero, Javier
    Calleja, Jose Luis
    Ibanez-Samaniego, Luis
    Aspichueta, Patricia
    Martin-Duce, Antonio
    Kushner, Tatyana
    Ortiz, Pablo
    Harrison, Stephen A.
    Anstee, Quentin M.
    Crespo, Javier
    Mato, Jose M.
    Sanyal, Arun J.
    HEPATOLOGY, 2024, 79 (01) : 135 - 148
  • [2] Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
    Noureddin, Mazen
    Truong, Emily
    Mayo, Rebeca
    Martinez-Arranz, Ibon
    Minchole, Itziar
    Banales, Jesus M.
    Arrese, Marco
    Cusi, Kenneth
    Arias-Loste, Maria Teresa
    Bruha, Radan
    Romero-Gomez, Manuel
    Iruzubieta, Paula
    Aller, Rocio
    Ampuero, Javier
    Calleja, Jose Luis
    Ibanez-Samaniego, Luis
    Aspichueta, Patricia
    Marin-Duce, Antonio
    Kushner, Tatyana
    Ortiz, Pablo
    Harrison, Stephen A.
    Anstee, Quentin M.
    Crespo, Javier
    Mato, Jose M.
    Sanyal, Arun J.
    HEPATOLOGY, 2025, 81 (01) : E12 - E16
  • [3] Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)
    Wang, Shuang
    Friedman, Scott L.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (716)
  • [4] Making The Cut: A Retrospective Analysis of Patients with Metabolic-Associated Fatty Liver Disease/Metabolic-Associated Steatohepatitis (MAFLD/MASH) Who Have Undergone Bariatric Surgery
    Ekanayake, Lakmal
    Johnson, Nicholas
    Ailawadi, Shaina
    Hindupur, Anay
    Lindner, Erika
    Currey, Erin L.
    Triplett, Drew
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1285 - S1285
  • [5] IMPACT OF SARCOPENIA AND ADVANCED FIBROSIS ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE
    Lee, Jae Chang
    Kim, Kye Whon
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Kweon, Young Oh
    Tak, Won Young
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY, 2022, 76 : S809 - S809
  • [6] Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis
    Wong, Robert J.
    Tran, Tram
    Kaufman, Harvey
    Niles, Justin
    Gish, Robert
    PLOS ONE, 2019, 14 (08):
  • [7] Assessing advanced fibrosis in metabolic-associated steatotic liver disease-The MAFLD fibrosis score
    Sharpton, Suzanne
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1234 - 1235
  • [8] Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgery
    Elsayed, Amr
    Hassnine, Alshymaa
    Gayyed, Mariana F.
    Saied, Fatma
    Abdelzaher, Mohamed A.
    Fouad, Yasser
    Mostafa, Alaa M.
    Khalaf, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 10 (04) : 240 - 248
  • [9] IMPACT OF FIBROSIS SEVERITY ON CLINICAL AND METAGENOMIC PROFILES IN MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) PATIENTS
    Joung, Hyunchae
    Joo, Jaeryang
    Kim, KyungHwan
    Shin, Chang Hun
    Lee, Hye Won
    HEPATOLOGY, 2024, 80 : S788 - S789
  • [10] DEGREE OF METABOLIC DYSFUNCTION IS LINKED TO STEATOHEPATITIS (MASH), FIBROSIS, AND HIGHER CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Kim, David
    Abboud, Yazan
    Ismail, Mohamed
    Goyal, Ritik Mahaveer
    Pyrsopoulos, Nikolaos
    Kim, Hyunseok
    Hajifathalian, Kaveh
    Al-Khazraji, Ahmed
    HEPATOLOGY, 2024, 80 : S441 - S442
12345